Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma

被引:9
|
作者
Lopez-Lopez, Victor [1 ]
Brusadin, Roberto [1 ]
Lopez-Conesa, Asuncion [1 ]
Capel, Antonio [2 ]
Navarro-Barrios, Alvaro [1 ]
Cayuela, Valentin [1 ]
Lopez-Banet, Elena [3 ]
Garzon-Arana, Alejandro [4 ]
Parrilla-Paricio, Pascual [1 ]
Robles-Campos, Ricardo [1 ]
机构
[1] IMIB ARRIXACA, Clin & Univ Hosp Virgen de la Arrixaca, Dept Gen Visceral & Transplantat Surg, Murcia, Spain
[2] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Intervent Radiol, Murcia, Spain
[3] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Radiol, Murcia, Spain
[4] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Surg Pathol, Murcia, Spain
关键词
Transarterial chemoembolization; Hepatocellular carcinoma; Laparoscopy; Liver resection; HEPATIC RESECTION; LONG-TERM; METAANALYSIS; OUTCOMES;
D O I
10.1007/s00423-020-02056-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose Laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) offers better short-term results than open surgery with similar long-term results although it is technically difficult due to the risk of bleeding. Methods This study included patients with HCC in Child A cirrhosis who underwent TACE before LLR between 2009 and 2019. The primary endpoint was to analyze the intraoperative and early results of this technique. We also analyzed the long-term outcomes. Patients with and without clinically significant portal hypertension (CSPH) were compared. Results A total of 44 cirrhotic patients with HCC were included (24 CSPH and 20 non-CSPH). The Pringle maneuver was used in two cases (4.5%), mean blood losses was 100 ml (range 50-200), and three patients (6.8%) required a blood transfusion. The degree of necrosis achieved was greater than 90% in 27 patients (61.4%). At 1, 3, and 5 years, overall survival was 97.7%, 81.5%, and 63.4%, respectively, and disease-free survival was 85.2%, 52.5%, and 34.5%, respectively. There were no statistically significant differences between non-CSPH and CSPH groups regarding intraoperative, early, and long-term outcomes. Conclusion In our experience, TACE could be beneficial to perform LLR in HCC Child-Pugh A patients with and without CSPH without serious complications and similar oncological outcomes.
引用
收藏
页码:763 / 771
页数:9
相关论文
共 50 条
  • [1] Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma
    Víctor Lopez-Lopez
    Roberto Brusadin
    Asunción López-Conesa
    Antonio Capel
    Álvaro Navarro-Barrios
    Valentín Cayuela
    Elena Lopez-Banet
    Alejandro Garzón-Arana
    Pascual Parrilla-Paricio
    Ricardo Robles-Campos
    Langenbeck's Archives of Surgery, 2021, 406 : 763 - 771
  • [2] Preoperative Transarterial Chemoembolization for Hepatocellular Carcinoma
    Kishi, Yoji
    Saiura, Akio
    Yamamoto, Junji
    Koga, Rintaro
    Seki, Makoto
    Morimura, Ryo
    Yoshioka, Ryuji
    Kokudo, Norihiro
    Yamaguchi, Toshiharu
    HEPATO-GASTROENTEROLOGY, 2012, 59 (119) : 2295 - 2299
  • [3] Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?
    Allard, Marc-Antoine
    Sebagh, Mylene
    Ruiz, Aldrick
    Guettier, Catherine
    Paule, Bernard
    Vibert, Eric
    Cunha, Antonio Sa
    Cherqui, Daniel
    Samuel, Didier
    Bismuth, Henri
    Castaing, Denis
    Adam, Rene
    JOURNAL OF HEPATOLOGY, 2015, 63 (01) : 83 - 92
  • [4] Liver Transplantation, Liver Resection, and Transarterial Chemoembolization for Hepatocellular Carcinoma in Cirrhosis: Which Is the Best Oncological Approach?
    Sotiropoulos, Georgios C.
    Druehe, Nina
    Sgourakis, George
    Molmenti, Ernesto P.
    Beckebaum, Susanne
    Baba, Hideo A.
    Antoch, Gerald
    Hilgard, Philip
    Radtke, Arnold
    Saner, Fuat H.
    Nadalin, Silvio
    Paul, Andreas
    Malago, Massimo
    Broelsch, Christoph E.
    Lang, Hauke
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (10) : 2264 - 2273
  • [5] Propensity score-based comparison of hepatic resection and transarterial chemoembolization for patients with advanced hepatocellular carcinoma
    Yuan, Bao-Hong
    Yuan, Wei-Ping
    Li, Ru-Hong
    Xiang, Bang-De
    Gong, Wen Feng
    Li, Le-Qun
    Zhong, Jian-Hong
    TUMOR BIOLOGY, 2016, 37 (02) : 2435 - 2441
  • [6] Hepatic resection versus transarterial chemoembolization for patients with Barcelona Clinic Liver Cancer intermediate stage Child-Pugh A hepatocellular carcinoma
    Zhao, Yin-Nong
    Zhang, Yong-Quan
    Ye, Jia-Zhou
    Liu, Xing
    Yang, Hong-Zhi
    Cong, Feng-Yun
    Xiang, Bang-De
    Wu, Fei-Xiang
    Ma, Liang
    Li, Le-Qun
    Ye, Hai-Hong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (06) : 3813 - 3819
  • [7] Critical systematic review on hepatic resection and transarterial chemoembolization for hepatocellular carcinoma
    Solaini, Leonardo
    Cucchetti, Alessandro
    Piccino, Marco
    Gardini, Andrea
    La Barba, Giuliano
    Serenari, Matteo
    Cescon, Matteo
    Ercolani, Giorgio
    FUTURE ONCOLOGY, 2019, 15 (04) : 439 - 449
  • [8] Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma
    Chen, Shuling
    Jin, Huilin
    Dai, Zihao
    Wei, Mengchao
    Xiao, Han
    Su, Tianhong
    Li, Bin
    Liu, Xin
    Wang, Yu
    Li, Jiaping
    Shen, Shunli
    Zhou, Qi
    Peng, Baogang
    Peng, Zhenwei
    Peng, Sui
    CANCER MEDICINE, 2019, 8 (04): : 1530 - 1539
  • [9] Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma
    Dong-Zhi Zhang
    Xiao-Dong Wei
    Xiao-Peng Wang
    World Journal of Gastroenterology, 2015, 21 (15) : 4635 - 4643
  • [10] Pathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection
    Kwang Yeol Paik
    Eung Kook Kim
    Hepatobiliary&PancreaticDiseasesInternational, 2016, 15 (02) : 158 - 164